Updated:
Jeekai & Partners
Jeekai & Partners was established in Beijing in 1998 by Robin R. Zhao, who continues to lead the firm as Senior Partner. The founding predates most structured...
Jeekai & Partners
Jeekai & Partners was established in Beijing in 1998 by Robin R. Zhao, who continues to lead the firm as Senior Partner. The founding predates most structured IP investment vehicles in China, positioning the firm as an early mover in the specialized intersection of intellectual property law and principal investment. Zhao's team includes patent administration head Mo Guo and a network of professionals affiliated with major industry bodies, reflecting a model built on legal-operational capability rather than traditional fund management. The firm concentrates exclusively on intellectual property markets, a narrow mandate that spans patent origination, acquisition, and monetization within China. Unlike generalist investment platforms, Jeekai operates as a corporate investor — taking direct stakes in IP assets, managing patent portfolios, and likely structuring royalty-based or enforcement-driven returns. Its historical and current deal book remains private, but the firm's sustained membership in the International Trademark Association (INTA), AIPPI, and the All-China Patent Agents Association (ACPAA) signals an embedded, institutionally networked approach to sourcing IP rights. Jeekai's corporate structure integrates professional service functions unusual for a pure investment firm — the patent administration department managed by Mo Guo suggests in-house prosecution and portfolio maintenance capabilities. Xiaoman Gu, a former partner, began her IP career at the firm, indicating a talent pipeline that blends legal training with investment execution. The firm also maintains a philanthropic vehicle, the Beijing Jiekai Cardiovascular Health Foundation, which operates as a separate entity under the family's broader interests. What distinguishes Jeekai structurally is its dual identity as both IP law firm and principal investor — a hybrid rare outside specialized litigation-finance circles in the West. While most Chinese family offices diversified into real estate or venture capital, Jeekai remained anchored in IP, developing what appears to be a proprietary sourcing engine through its deep ties to China's patent examination and trademark adjudication infrastructure. The firm's long tenure without external fund cycles suggests permanent, patient capital consistent with a single-family or closely held corporate balance sheet.
General information
Firm type
Corporate Investor
Year founded
1998
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Principals
Robin R. Zhao
Senior Partner & Founder
Mo Guo
Manager, Patent Administration Department
Xiaoman Gu
Former Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Jeekai & Partners?
Founder Robin R. Zhao serves as Senior Partner and is the key investment decision-maker for the firm. Zhao has led Jeekai since its 1998 founding, steering its focus on intellectual property markets in China. Investment execution is supported by a dedicated patent administration team under Mo Guo, indicating decisions are informed by in-house legal and technical expertise.
What does Jeekai & Partners actually invest in?
Jeekai concentrates on intellectual property assets — primarily patents and trademarks within China. The firm originates, acquires, and manages IP portfolios as a corporate investor, meaning it directly owns the assets rather than operating a third-party fund. This investment focus covers the full lifecycle of IP, from prosecution to monetization.
Is Jeekai structured as a family office or a corporate investor?
Jeekai is classified as a corporate investor, not a traditional single-family office. The firm is closely held and operates with permanent capital characteristic of family-backed entities, but its legal and operational architecture — including an in-house patent administration department — more closely resembles an operating company making principal investments in IP.
How does Jeekai source intellectual property deals?
The firm is deeply embedded in China's IP professional ecosystem. It holds memberships in the International Trademark Association (INTA), AIPPI, and the All-China Patent Agents Association (ACPAA), which provide structural access to patent applicants, trademark filers, and enforcement actions. This network-based sourcing model is paired with in-house patent prosecution capabilities that can surface investment opportunities during the application process.
Does Jeekai & Partners manage outside capital?
The firm has not publicly disclosed any external fund structures. Its corporate investor designation and long operating history since 1998 suggest Jeekai deploys proprietary capital, likely originating from its founder or a closely held balance sheet. No regulatory filings indicating third-party fund management have been identified in public record.
What is the Beijing Jiekai Cardiovascular Health Foundation?
The Beijing Jiekai Cardiovascular Health Foundation is a philanthropic entity maintained separately from Jeekai & Partners' investment activities. It reflects the firm's or founder's broader interests in healthcare philanthropy within China. There is no public indication of commingling between the foundation's assets and Jeekai's IP investment operations.
Does Jeekai invest outside China?
Jeekai's primary investment geography is China, where it targets domestic intellectual property markets. Its membership in international associations like INTA and AIPPI provides global professional connections, but the firm has not disclosed cross-border IP investments or offices outside Beijing. Its mandate appears concentrated on Chinese-originated patent and trademark assets.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: